875 E. Wisconsin Ave,Suite 800
Milwaukee , WI, 53202
Milwaukee , WI, 53202
Summary
The fund seeks maximum capital appreciation in the long term by investing in small-size companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team seeks to invest in companies demonstrating growth potential.
The team favors More
Link
Directors
Dec 14, 2023- Coleen Downs Dinneen
- Gregory K. Ramirez
- Peter M. Lebovitz
- Peter E. Sundman
- Gail L. Hanson
- Bonnie L. Howard
- William J. Kelly
Chief Compliance Officer
- Jill M. Demski
Fund Manager(s)
- Craigh Cepukenas
- James Hamel
- Matthew Kamm
- Jason White
- Jay Warner
Price
- 52-Week High/Low
- $40.22 - $30.63
- Turnover
- 33.6%
- Expense Ratio
- 1.23%
Company Name |
Holding |
| Halozyme Therapeutics, Inc. | 5.82 % |
| Guidewire Software, Inc. | 5.23 % |
| Lattice Semiconductor Corp. | 4.72 % |
| Ascendis Pharma A/S | 4.54 % |
| Argenx SE | 4.38 % |
| SPX Technologies, Inc. | 3.65 % |
| Twist Bioscience Corp. | 3.24 % |
| Tyler Technologies, Inc. | 2.97 % |
| MACOM Technology Solutions Holdings, Inc. | 2.94 % |
| Novanta, Inc. | 2.82 % |
| More | 2.82 % |
Advisor
Documents
Performance
YTD
-
3 Year
-14.93%
5 Year
4.86%
Best
52.13%
2020
Worst
-43.93%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 9.4% | 7.6% | -18% | 5.9% | -15% | 23% | 7.6% | 9.5% | -6.3% |
| Q2 | - | -3.7% | 1.1% | -21.5% | 4.4% | 37.3% | 5.9% | 10% | 5.6% | 8.8% |
| Q3 | - | - | -8% | 3.2% | -11.4% | 2.6% | -4% | 9.6% | 3.8% | 9.5% |
| Q4 | - | - | 10.2% | 6% | -7.1% | 13.9% | 1.8% | -18.7% | 4.8% | -5.4% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -2.7% | 9.8% | 2.4% | -4.6% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 4% | 9% | -30% | -19% | 52% | 30% | 2% | 27% | 0% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ARTSX | - | 4% | 9% | -30% | -19% | 52% | 30% | 2% | 27% | - |
| Russell 2000 | - | - | - | -32% | 2% | 34% | 28% | -10% | 21% | 10% |
| Alpha | - | 4% | 9% | 2% | -21% | 18% | 2% | 12% | 6% | - |